Impact of early dose intensity on cytogenetic and molecular responses in chronic-phase CML patients receiving 600 mg/day of inhatinib as initial therapy

• HUGHES T

収録刊行物

• Blood

  Blood 112 3965-3973, 2008

詳細情報

• CRID: 1570009750846410496
• NII論文ID: 10030954515
• データソース種別:
  • CiNii Articles